Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Preferred Shares Issued: 2010-2024

Historic Preferred Shares Issued for Northwest Biotherapeutics (NWBO) over the last 4 years, with Sep 2024 value amounting to $267,000.

  • Northwest Biotherapeutics' Preferred Shares Issued fell 94.81% to $267,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $11.6 million, marking a year-over-year decrease of 34.15%. This contributed to the annual value of $8.2 million for FY2024, which is 38.48% down from last year.
  • According to the latest figures from Q3 2024, Northwest Biotherapeutics' Preferred Shares Issued is $267,000, which was down 93.81% from $4.3 million recorded in Q2 2024.
  • Over the past 5 years, Northwest Biotherapeutics' Preferred Shares Issued peaked at $10.9 million during Q3 2022, and registered a low of $267,000 during Q3 2024.
  • In the last 3 years, Northwest Biotherapeutics' Preferred Shares Issued had a median value of $3.6 million in 2024 and averaged $4.5 million.
  • Over the last 5 years, Northwest Biotherapeutics' Preferred Shares Issued had its largest YoY gain of 81.78% in 2024, and its largest YoY loss of 94.81% in 2024.
  • Over the past 3 years, Northwest Biotherapeutics' Preferred Shares Issued (Quarterly) stood at $7.8 million in 2022, then tumbled by 55.81% to $3.4 million in 2023, then slumped by 94.81% to $267,000 in 2024.
  • Its Preferred Shares Issued stands at $267,000 for Q3 2024, versus $4.3 million for Q2 2024 and $3.6 million for Q1 2024.